Johnson, Isla M. http://orcid.org/0000-0002-3290-5213
Scheckel, Caleb http://orcid.org/0000-0002-7248-2219
Parikh, Sameer A. http://orcid.org/0000-0002-3221-7314
Enzler, Mark
Fugate, Jennifer
Call, Timothy G.
Article History
Received: 23 May 2022
Revised: 6 September 2022
Accepted: 14 September 2022
First Online: 7 October 2022
Competing interests
: Research funding has been provided to the institution from Pharmacyclics, Janssen, AstraZeneca, TG Therapeutics, Merck, AbbVie, and Ascentage Pharma for clinical studies in which SP is a principal investigator. SP has received honoraria for participation in consulting activities/advisory board meetings for Pharmacyclics, Merck, AstraZeneca, Genentech, GlaxoSmithKline, Adaptive Biotechnologies, Amgen, and AbbVie (no personal compensation); and from DynaMed, Aptitude Health, Curio Science, and MedEd on the Go (with personal compensation). The remaining authors declare no competing interests.
: Informed consent was obtained in accordance with Mayo Clinic policies.